Swiss National Bank
TNGX icon

Swiss National Bank’s Tango Therapeutics TNGX Stock Holding History

Swiss National Bank’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.86M Buy
187,400
+99,600
+113% +$2.46M ﹤0.01% 1353
2026
Q1 		$1.84M Hold
87,800
– – ﹤0.01% 1893
2025
Q4 		$778K Buy
+87,800
New +$757K ﹤0.01% 2239
2025
Q1 		– Sell
-94,900
Closed -$293K – 2449
2024
Q4 		$293K Buy
94,900
+11,000
+13% +$51.1K ﹤0.01% 2432
2024
Q3 		$646K Hold
83,900
– – ﹤0.01% 2370
2024
Q2 		$720K Buy
83,900
+3,700
+5% +$28.6K ﹤0.01% 2309
2024
Q1 		$637K Hold
80,200
– – ﹤0.01% 2404
2023
Q4 		$794K Sell
80,200
-19,300
-19% -$168K ﹤0.01% 2358
2023
Q3 		$1.12M Sell
99,500
-15,700
-14% -$95.7K ﹤0.01% 2179
2023
Q2 		$382K Buy
115,200
+10,600
+10% +$38.1K ﹤0.01% 2577
2023
Q1 		$413K Sell
104,600
-12,300
-11% -$71.4K ﹤0.01% 2567
2022
Q4 		$848K Buy
116,900
+44,600
+62% +$314K ﹤0.01% 2421
2022
Q3 		$262K Hold
72,300
– – ﹤0.01% 2675
2022
Q2 		$328K Sell
72,300
-20,800
-22% -$126K ﹤0.01% 2704
2022
Q1 		$706K Buy
93,100
+6,400
+7% +$55.5K ﹤0.01% 2525
2021
Q4 		$948K Buy
+86,700
New +$1.04M ﹤0.01% 2501

Other funds holding TNGX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Swiss National Bank's TNGX Position: Q2 2026 in Review

Swiss National Bank increased its Tango Therapeutics (TNGX) stake by 113% in Q2 2026, buying an estimated $2.46M and bringing the position to 187,400 shares worth $5.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

Swiss National Bank first reported a position in TNGX in Q4 2021 and has held it in 16 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Swiss National Bank held 187,400 shares of Tango Therapeutics worth $5.86M as of Q2 2026.
  • Swiss National Bank bought 99,600 Tango Therapeutics shares in Q2 2026, an estimated $2.46M.
  • Tango Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1353 holding.
  • Swiss National Bank first reported a position in Tango Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.